Pleasanton, California-based Spirosure (previously known as Spirometrix) has raised $15 million in Series C-2 financing for its breath analysis device, according to a statement. The funding round was led by returning investor NGK Spark Plugs Co. Ltd. of Japan, as well as other unnamed investors.
from MobiHealthNews http://ift.tt/2ErUPBD
January 09, 2018
Rose
MobiHealthNews
No comments
Related Posts:
EHR CareCloud delivers in first year of 'MIPS Success Guarantee'In the first year of CMS’ Merit-based Incentive Payment System (MIPS), CareCloud, an EHR and practice management software company that offers a MIPS Success Guarantee Program to its users, is reporting that 100 percent of its… Read More
AHA, Philips, UPMC launch $30M venture fund for cardiovascular innovationThe American Heart Association, the University of Pittsburgh Medical Center, and healthcare tech company Royal Philips have partnered to finance a new $30 million venture fund, according to a statement. Called Cardeation Capi… Read More
UK government looks to AI to prevent disease, boost industryThe British government is now turning to artificial intelligence as an avenue for early cancer and chronic disease detection. This morning, Prime Minister Theresa May announced plans to invest in AI technology development for… Read More
Employee wellness platforms Virgin Pulse, RedBrick Health to mergeThis morning, the employee wellness and health engagement platforms Virgin Pulse and RedBrick Health announced that they are merging under the Virgin Pulse name. The merger comes after Marlin Equity Partners' acquisition of R… Read More
Patient engagement, care coordination company CipherHealth raises $37.6M investmentPatient engagement and care coordination technology company CipherHealth has raised approximately $37.6 million in funding, according to a recent SEC filing. The funding was led by JMI Equity. from MobiHealthNews https://ift… Read More
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment